Please use this identifier to cite or link to this item:
|Title:||Therapeutic modulation of microbiota-host metabolic interactions||Authors:||Holmes, Elaine
Gibson, Glenn R.
Nicholson, Jeremy K.
|Keywords:||DRNTU::Science::Biological sciences||Issue Date:||2012||Source:||Holmes, E., Kinross, J., Gibson, G. R., Burcelin, R., Jia, W., Pettersson, S., et al. (2012). Therapeutic Modulation of Microbiota-Host Metabolic Interactions. Science Translational Medicine, 4(137).||Series/Report no.:||Science translational medicine||Abstract:||The complex metabolic relationships between the host and its microbiota change throughout life and vary extensively between individuals, affecting disease risk factors and therapeutic responses through drug metabolism. Elucidating the biochemical mechanisms underlying this human supraorganism symbiosis is yielding new therapeutic insights to improve human health, treat disease, and potentially modify human disease risk factors. Therapeutic options include targeting drugs to microbial genes or co-regulated host pathways and modifying the gut microbiota through diet, probiotic and prebiotic interventions, bariatric surgery, fecal transplants, or ecological engineering. The age-associated co-development of the host and its microbiota provides a series of windows for therapeutic intervention from early life through old age.||URI:||https://hdl.handle.net/10356/97843
|DOI:||http://dx.doi.org/10.1126/scitranslmed.3004244||Rights:||© 2012 American Association for the Advancement of Science.||Fulltext Permission:||none||Fulltext Availability:||No Fulltext|
|Appears in Collections:||SBS Journal Articles|
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.